Skip to content

Arteris, Inc. AIP Accrued expenses and other liabilities

Accrued expenses and other liabilities at other companies

AMB
Ambiq Micro, Inc.AMBQ
Onto Innovation logo
Onto InnovationONTO
Astera Labs, Inc. logo
Astera Labs, Inc.ALAB

Other financials

Income statement

See full
Revenue$22.9M+38.7%
Gross profit$19.7M+31.2%
Operating income-$9.3M-20.7%
Net income-$8.0M+2.0%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$12.0M-28.3%
Total debt$5.5M+20.2%
Total equity$2.6M+154%
Total assets$139.9M+42.3%

Cash flow

See full
Operating cash flow-$7.1M-347%
CapEx$295.0K+61.2%
Free cash flow-$7.4M-375%

Valuation

See full
Market cap$1.89B+164%

Profitability

See full
Gross margin88.8%-1.4pp
Operating margin-45.1%-3.5pp
Net margin-44.9%-5.8pp
FCF margin-6.1%-8.3pp

Returns & leverage

See full
Return on equity-296.8%-687pp
Debt / equity2.1×
Current ratio0.7×-0.3×

Where this comes from

Reported directly by Arteris, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.

The official record: Arteris, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arteris, Inc.'s accrued expenses and other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arteris, Inc.'s accrued expenses and other liabilities?
Arteris, Inc. (AIP) reported accrued expenses and other liabilities of -$6.34M in Q1 2026.
How has Arteris, Inc.'s accrued expenses and other liabilities changed year-over-year?
Arteris, Inc.'s accrued expenses and other liabilities decreased by 220.7% year-over-year, from -$1.98M to -$6.34M.
What is the long-term trend for Arteris, Inc.'s accrued expenses and other liabilities?
Over 3 years (2021 to 2025), Arteris, Inc.'s accrued expenses and other liabilities has grown at a 4.7% compound annual growth rate (CAGR), from $2.84M to $3.25M.